| 1 |
35162972 | Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection. | 2022 Jan 19 |
1 |
| 2 |
32277367 | Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. | 2020 Jul |
1 |
| 3 |
32366740 | COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence? | 2020 Jul/Aug |
3 |
| 4 |
32415494 | COVID-19 pandemic and therapy with ibuprofen or renin-angiotensin system blockers: no need for interruptions or changes in ongoing chronic treatments. | 2020 Jul |
2 |
| 5 |
32506743 | No current evidence supporting risk of using Ibuprofen in patients with COVID-19. | 2020 Oct |
1 |
| 6 |
32797326 | A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality. | 2020 Oct |
1 |